Replies to post #743600 on NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

tunnelvisionofplenty,

Illuccix® (gallium-68 gozetotide) received European approval on January 17. I expect a similar approval in the United Kingdom in the coming days.

If the approval goes through, it seems that mRESVIA may be the last candidate remaining in the pipeline ahead of DCVax-L.

https://www.prnewswire.com/apac/news-releases/illuccix-receives-european-approval-302353727.html